SCHEMBL5045407

SCHEMBL5045407

N#Cc1ccc(/C=N\O)c(OCC(F)(F)F)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
APP P05067 1/20 0.42
SLC6A9 P48067 1/20 0.37
KCNH2 Q12809 1/20 0.37
CYP11B1 P15538 1/20 0.36
CYP11B2 P19099 1/20 0.36
ALDH1A1 P00352 3/20 0.35
PTGDR2 Q9Y5Y4 3/20 0.35
MRGPRX4 Q96LA9 1/20 0.35
HCRTR1 O43613 1/20 0.35
HCRTR2 O43614 1/20 0.35
HPGD P15428 4/20 0.35
TSHR P16473 3/20 0.35
HSD17B10 Q99714 2/20 0.35
MAPK1 P28482 1/20 0.35
USP2 O75604 2/20 0.35
LMNA P02545 1/20 0.35
ENPP2 Q13822 1/20 0.35
CCR5 P51681 1/20 0.34
SSTR4 P31391 1/20 0.34
KDM4E B2RXH2 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5045411 1.00 APP (0.42) APPSLC6A9KCNH2CYP11B1CYP11B2
SCHEMBL5043182 0.82 APP (0.42) APPSLC6A9KCNH2CYP11B1CYP11B2
SCHEMBL30275270 0.77 TRPV4 (0.45) APPKCNH2MRGPRX4MAPT
SCHEMBL1794498 0.77 AR (0.44) ALDH1A1HPGDLMNAKDM4EMEN1
SCHEMBL1794499 0.77 AR (0.44) ALDH1A1HPGDLMNAKDM4EMEN1
SCHEMBL25042671 0.77 TRPV4 (0.45) APPKCNH2MRGPRX4MAPT
SCHEMBL20007300 0.77 SSTR4 (0.42) APPSLC6A9KCNH2ALDH1A1PTGDR2
SCHEMBL28952492 0.77 TRPV4 (0.45) APPKCNH2MRGPRX4MAPT
SCHEMBL31294779 0.75 PTGDR2 (0.45) SLC6A9KCNH2CYP11B1CYP11B2ALDH1A1
SCHEMBL31294730 0.75 PTGDR2 (0.47) SLC6A9KCNH2CYP11B1CYP11B2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1567498-B1 MANDELIC ACID DERIVATIVES HOFFMANN LA ROCHE (CH) 2008-01-23 EP disclosed
US-7129238-B2 Mandelic acid derivatives HOFFMANN-LA ROCHE INC. (US) 2006-10-31 US disclosed
EP-1567498-A2 MANDELIC ACID DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2005-08-31 EP disclosed
US-20040122057-A1 Novel mandelic acid derivatives HOFFMANN-LA ROCHE INC. 2004-06-24 US disclosed
WO-2004048335-A2 MANDELIC ACID DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2004-06-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040122057-A1 Novel mandelic acid derivatives F7, F11, F9 APP 4301/4885SLC6A9 1529/4885KCNH2 4519/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.